Vitamin D in preventive medicine

Anticancer Research

Volumn 35, Issue 2, 2015, Pages 1161-1170

  Pilz, Stefan ^a,b   Gaksch, Martin ^a   Hartaigh, Bríain Ó ^c,d   Tomaschitz, Andreas ^a,e   März, Winfried ^a,f,g  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Specialist Clinic of Rehabilitation PV Bad Aussee   (Austria)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g SYNLAB ACADEMY   (Germany)

Author keywords

25(OH)D; Cancer; Epidemiology; Preventive medicine; Review; Vitamin D

Indexed keywords

VITAMIN D;

HEALTH CARE POLICY; HUMAN; PREVENTIVE MEDICINE;

HUMANS; NUTRITION POLICY; PREVENTIVE MEDICINE; VITAMIN D;

EID: 84922860856     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (104)

1. Holick MF: McCollum Award Lecture, 1994: vitamin D - new horizons for the 21st century. Am J Clin Nutr 60: 619-630, 1994.
2. Prentice A: Nutritional rickets around the world. J Steroid Biochem Mol Biol 136: 201-206, 2013.
3. Winzenberg T and Jones G: Vitamin D and bone health in childhood and adolescence. Calcif Tissue Int 92: 140-150, 2013.
4. Lips P: Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22: 477-501, 2001
5. Bhan A, Rao AD and Rao DS: Osteomalacia as a result of vitamin D deficiency. Rheum Dis Clin North Am 38: 81-91, 2012.
6. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ, Kienreich K and Soni M: Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-A review of recent evidence. Autoimmun Rev 12: 976-989, 2013.
7. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Murad MH and Kovacs CS: The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 33: 456-492, 2012.
8. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C and Demay M: Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29: 726-776, 2008.
9. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH and Weaver CM: Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 97: 1153-1158, 2012.
10. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA and Taylor CL: IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 97: 1146-1152, 2012.
11. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, Bischoff-Ferrari HA, Cavalier E, Ebeling PR, Fardellone P, Gandini S, Gruson D, Guérin AP, Heickendorff L, Hollis BW, Ish-Shalom S, Jean G, von Landenberg P, Largura A, Olsson T, Pierrot-Deseilligny C, Pilz S, Tincani A, Valcour A and Zittermann A: Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 9: 709-715, 2010.
12. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R and Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF): European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24: 23-57, 2013.
13. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stähelin HB, Theiler R and Dawson-Hughes B: A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367: 40-49, 2012.
14. Bolland MJ, Grey A, Gamble GD and Reid IR: The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2: 307-320, 2014.
15. Moyer VA; U.S. Preventive Services Task Force: Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 158: 691-696, 2013.
16. Reid IR, Bolland MJ and Grey A: Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383: 146-155, 2014.
17. Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, Feskens EJ, Gallagher CJ, Hypponen E, Llewellyn DJ, Stoecklin E, Dierkes J, Kies AK, Kok FJ, Lamberg-Allardt C, Moser U, Pilz S, Saris WH, van Schoor NM, Weber P, Witkamp R, Zittermann A and de Groot LC: Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int 24: 1567-1577, 2013.
18. Bolland MJ, Grey A, Gamble GD and Reid IR: Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2: 573-580, 2014.
19. Bolland MJ, Grey A and Reid IR: Differences in overlapping meta-analyses of vitamin D supplements and falls. J Clin Endocrinol Metab. 2014 Aug 5:jc20142562.
20. Murad MH, Elamin KB, Abu Elnour NO, Elamin MB, Alkatib AA, Fatourechi MM, Almandoz JP, Mullan RJ, Lane MA, Liu H, Erwin PJ, Hensrud DD and Montori VM: Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 96: 2997-3006, 2011.
21. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH and Weaver CM; Endocrine Society: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 1911-1930, 2011.
22. Theodoratou E, Tzoulaki I, Zgaga L and Ioannidis JP: Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348: g2035, 2014.
23. Lips P, Gielen E and van Schoor NM: Vitamin D supplements with or without calcium to prevent fractures. Bonekey Rep 3: 512, 2014.
24. Apperly FL: The Relation of Solar Radiation to Cancer Mortality in North America. Cancer Res 1: 191-195, 1941.
25. Pilz S: Vitamin D and cancer: current evidence and future perspective. Anticancer Agents Med Chem 13: 2-3, 2013.
26. Garland CF and Garland FC: Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9: 227-231, 1980.
27. Grant WB: Update on evidence that support a role of solar ultraviolet-B irradiance in reducing cancer risk. Anticancer Agents Med Chem 13: 140-146, 2013.
28. Mason RS and Reichrath J: Sunlight vitamin D and skin cancer. Anticancer Agents Med Chem 13: 83-97, 2013.
29. Chiang KC and Chen TC: The anti-cancer actions of vitamin D. Anticancer Agents Med Chem 13: 126-139, 2013.
30. Höbaus J, Thiem U, Hummel DM and Kallay E: Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis. Anticancer Agents Med Chem 13: 20-35, 2013.
31. Pilz S, Kienreich K, Tomaschitz A, Ritz E, Lerchbaum E, Obermayer-Pietsch B, Matzi V, Lindenmann J, März W, Gandini S and Dekker JM: Vitamin D and cancer mortality: systematic review of prospective epidemiological studies. Anticancer Agents Med Chem 13: 107-117, 2013.
32. Yin L, Ordóñez-Mena JM, Chen T, Schöttker B, Arndt V and Brenner H: Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis. Prev Med 57: 753-764, 2013.
33. Pilz S, Tomaschitz A, Obermayer-Pietsch B, Dobnig H and Pieber TR: Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res 29: 3699-3704, 2009.
34. Mohr SB, Gorham ED, Kim J, Hofflich H and Garland CF: Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer Res 34: 1163-1166, 2014.
35. Lazzeroni M, Serrano D, Pilz S and Gandini S: Vitamin D supplementation and cancer: review of randomized controlled trials. Anticancer Agents Med Chem 13: 118-125, 2013.
36. Keum N and Giovannucci E: Vitamin D supplements and cancer incidence and mortality: a meta-analysis. Br J Cancer 111: 976-980, 2014.
37. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M and Gluud C: Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1: CD007470, 2014.
38. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Krstic G, Wetterslev J and Gluud C: Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst Rev 6: CD007469, 2014.
39. Pilz S, Gaksch M, O'Hartaigh B, Tomaschitz A and März W: The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013? Arch Toxicol 87: 2083-2103, 2013.
40. Pilz S, Tomaschitz A, Drechsler C, Zittermann A, Dekker JM and März W: Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets 12: 88-96, 2011.
41. Muscogiuri G, Sorice GP, Ajjan R, Mezza T, Pilz S, Prioletta A, Scragg R, Volpe SL, Witham MD and Giaccari A: Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr Metab Cardiovasc Dis 22: 81-87, 2012.
42. Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A and Witham M; for the RECORD Trial Group: Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 100: 746-755, 2014.
43. Kunutsor SK, Burgess S, Munroe PB and Khan H: Vitamin D and high blood pressure: causal association or epiphenomenon? Eur J Epidemiol 29: 1-14, 2014.
44. Vimaleswaran KS, Cavadino A, Berry DJ; LifeLines Cohort Study investigators, Jorde R, Dieffenbach AK, Lu C, Alves AC, Heerspink HJ, Tikkanen E, Eriksson J, Wong A, Mangino M, Jablonski KA, Nolte IM, Houston DK, Ahluwalia TS, van der Most PJ, Pasko D, Zgaga L, Thiering E, Vitart V, Fraser RM, Huffman JE, de Boer RA, Schöttker B, Saum KU, McCarthy MI, Dupuis J, Herzig KH, Sebert S, Pouta A, Laitinen J, Kleber ME, Navis G, Lorentzon M, Jameson K, Arden N, Cooper JA, Acharya J, Hardy R, Raitakari O, Ripatti S, Billings LK, Lahti J, Osmond C, Penninx BW, Rejnmark L, Lohman KK, Paternoster L, Stolk RP, Hernandez DG, Byberg L, Hagström E, Melhus H, Ingelsson E, Mellström D, Ljunggren O, Tzoulaki I, McLachlan S, Theodoratou E, Tiesler CM, Jula A, Navarro P, Wright AF, Polasek O; International Consortium for Blood Pressure (ICBP); Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium; Global Blood Pressure Genetics (Global BPGen) consortium; Caroline Hayward, Wilson JF, Rudan I, Salomaa V, Heinrich J, Campbell H, Price JF, Karlsson M, Lind L, Michaëlsson K, Bandinelli S, Frayling TM, Hartman CA, Sørensen TI, Kritchevsky SB, Langdahl BL, Eriksson JG, Florez JC, Spector TD, Lehtimäki T, Kuh D, Humphries SE, Cooper C, Ohlsson C, März W, de Borst MH, Kumari M, Kivimaki M, Wang TJ, Power C, Brenner H, Grimnes G, van der Harst P, Snieder H, Hingorani AD, Pilz S, Whittaker JC, Järvelin MR and Hyppönen E: Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol 2: 719-729, 2014.
45. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD 3rd, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Mohd Hanafiah K, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CD, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope CA 3rd, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield K, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K, Stöckl H, Stovner LJ, Straif K, Straney L, Thurston GD, Tran JH, Van Dingenen R, van Donkelaar A, Veerman JL, Vijayakumar L, Weintraub R, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, Wilson N, Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CJ, Ezzati M, AlMazroa MA and Memish ZA: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2224-2260, 2012.
46. Melamed ML, Michos ED, Post W and Astor B: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168: 1629-1637, 2008.
47. Schöttker B, Haug U, Schomburg L, Köhrle J, Perna L, Müller H, Holleczek B and Brenner H: Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr 97: 782-793, 2013.
48. Schöttker B, Saum KU, Perna L, Ordóñez-Mena JM, Holleczek B and Brenner H: Is vitamin D deficiency a cause of increased morbidity and mortality at older age or simply an indicator of poor health? Eur J Epidemiol 29: 199-210, 2014.
49. Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO and Dobnig H: Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 93: 3927-3935, 2008.
50. Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF and Börgermann J: Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur Heart J 34: 1358-1364, 2013.
51. Pilz S, Tomaschitz A, Friedl C, Amrein K, Drechsler C, Ritz E, Boehm BO, Grammer TB and März W: Vitamin D status and mortality in chronic kidney disease. Nephrol Dial Transplant 26: 3603-3609, 2011.
52. Putz-Bankuti C, Pilz S, Stojakovic T, Scharnagl H, Pieber TR, Trauner M, Obermayer-Pietsch B and Stauber RE: Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int 32: 845-851, 2012.
53. Thomas GN, ó Hartaigh B, Bosch JA, Pilz S, Loerbroks A, Kleber ME, Fischer JE, Grammer TB, Böhm BO and März W: Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Diabetes Care 35: 1158-1164, 2012.
54. Pilz S, Dobnig H, Tomaschitz A, Kienreich K, Meinitzer A, Friedl C, Wagner D, Piswanger-Sölkner C, März W and Fahrleitner-Pammer A: Low 25-hydroxyvitamin D is associated with increased mortality in female nursing home residents. J Clin Endocrinol Metab 97: E653-657, 2012.
55. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V and Gandini S: Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies Am J Clin Nutr 95: 91-100, 2012.
56. Pilz S, Iodice S, Zittermann A, Grant WB and Gandini S: Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 58: 374-382, 2011.
57. Schöttker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot Ld, Streppel M, Gardiner J, Ordóñez-Mena JM, Perna L, Wilsgaard T, Rathmann W, Feskens E, Kampman E, Siganos G, Njølstad I, Mathiesen EB, Kubínová R, Paja¸k A, Topor-Madry R, Tamosiunas A, Hughes M, Kee F, Bobak M, Trichopoulou A, Boffetta P and Brenner H; Consortium on Health and Ageing: Network of Cohorts in Europe and the United States: Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 348: g3656, 2014.
58. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB and Franco OH: Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348: g1903, 2014.
59. Michaëlsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundström J, Berglund L, Arnlöv J, Hellman P, Blomhoff R, Wolk A, Garmo H, Holmberg L and Melhus H: Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 92: 841-848, 2010.
60. Sempos CT, Durazo-Arvizu RA, Dawson-Hughes B, Yetley EA, Looker AC, Schleicher RL, Cao G, Burt V, Kramer H, Bailey RL, Dwyer JT, Zhang X, Gahche J, Coates PM and Picciano MF: Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES. J Clin Endocrinol Metab 98: 3001-3009, 2013.
61. Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, Sanders KM, Salovaara K, Cooper C, Smith HE, Jacobs ET, Torgerson D, Jackson RD, Manson JE, Brixen K, Mosekilde L, Robbins JA, Francis RM and Abrahamsen B: Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab 97: 2670-2681, 2012.
62. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ and Shapses SA: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96: 53-58, 2011.
63. Cashman KD and Kiely M: Recommended dietary intakes for vitamin D: where do they come from, what do they achieve and how can we meet them? J Hum Nutr Diet 27: 434-442, 2014.
64. Cashman KD and Kiely M: EURRECA-Estimating vitamin D requirements for deriving dietary reference values. Crit Rev Food Sci Nutr 53: 1097-1109, 2013.
65. Wise J: NICE advises certain groups to take daily vitamin D supplement. BMJ. 2014 May 15;348:g3349.
66. German Nutrition Society: New reference values for vitamin D. Ann Nutr Metab 60: 241-6, 2012.
67. Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, Pierroz DD, Weber P and Hoffmann K: A systematic review of vitamin D status in populations worldwide. Br J Nutr 111: 23-45, 2014.
68. Wahl DA, Cooper C, Ebeling PR, Eggersdorfer M, Hilger J, Hoffmann K, Josse R, Kanis JA, Mithal A, Pierroz DD, Stenmark J, Stöcklin E and Dawson-Hughes B: A global representation of vitamin D status in healthy populations. Arch Osteoporos 7: 155-172, 2012.
69. Hintzpeter B, Mensink GB, Thierfelder W, Müller MJ and Scheidt-Nave C: Vitamin D status and health correlates among German adults. Eur J Clin Nutr 62: 1079-1089, 2008.
70. Calvo MS, Whiting SJ and Barton CN: Vitamin D intake: a global perspective of current status. J Nutr 135: 310-316, 2005.
71. Kiely M and Black LJ: Dietary strategies to maintain adequacy of circulating 25-hydroxyvitamin D concentrations. Scand J Clin Lab Invest Suppl 243: 14-23, 2012.
72. Carter GD: 25-hydroxyvitamin D: a difficult analyte. Clin Chem 58: 486-488, 2012.
73. Lips P, Chapuy MC, Dawson-Hughes B, Pols HA and Holick MF: An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 9: 394-397, 1999.
74. Schmid J, Kienreich K, Gaksch M, Grübler M, Raggam R, Meinitzer A, Rutters F, Dekker JM, März W, Verheyen N, Tomaschitz A and Pilz S: The importance of assays in vitamin D status classification: a comparison of four automated 25-hydroxyvitamin D immunoassays. LaboratoriumsMedizin 37: 261-268, 2013.
75. Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE, DeLuca HF and Drezner MK: Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 89: 3152-3157, 2004.
76. Cashman KD, Kiely M, Kinsella M, Durazo-Arvizu RA, Tian L, Zhang Y, Lucey A, Flynn A, Gibney MJ, Vesper HW, Phinney KW, Coates PM, Picciano MF and Sempos CT: Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data: a case study of the program's potential for national nutrition and health surveys. Am J Clin Nutr 97: 1235-1242, 2013.
77. Sempos CT, Vesper HW, Phinney KW, Thienpont LM and Coates PM: Vitamin D Standardization Program (VDSP): Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl 243: 32-40, 2012.
78. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR and Thadhani R: Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369: 1991-2000, 2013.
79. Binkley N and Wiebe D: Clinical controversies in vitamin D: 25(OH)D measurement, target concentration, and supplementation. J Clin Densitom 6: 402-408, 2013.
80. Heaney RP, Armas LA and French C: All-source basal vitamin D inputs are greater than previously thought and cutaneous inputs are smaller. J Nutr 143: 571-575, 2013.
81. Romagnoli E, Pepe J, Piemonte S, Cipriani C and Minisola S: Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur J Endocrinol 169: R59-69, 2013.
82. Autier P, Boniol M, Pizot C and Mullie P: Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2: 76-89, 2014.
83. Murr C, Pilz S, Grammer TB, Kleber ME, Meinitzer A, Boehm BO, Marz W and Fuchs D: Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chem Lab Med 50: 2205-2212, 2012.
84. Kühn T, Kaaks R, Teucher B, Hirche F, Dierkes J, Weikert C, Katzke V, Boeing H, Stangl GI and Buijsse B: Dietary, lifestyle, and genetic determinants of vitamin D status: a cross-sectional analysis from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Eur J Nutr 53: 731-741, 2014.
85. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA): Scientific opinion on the tolerable upper intake level of vitamin D. EFSA Journal 10: 2813: 1-45, 2012.
86. Zittermann A, Prokop S, Gummert JF and Börgermann J: Safety issues of vitamin D supplementation. Anticancer Agents Med Chem 13: 4-10, 2013.
87. Cashman KD, Fitzgerald AP, Kiely M and Seamans KM: A systematic review and meta-regression analysis of the vitamin D intake-serum 25-hydroxyvitamin D relationship to inform European recommendations. Br J Nutr 106: 1638-1648, 2011.
88. Jorde R, Strand Hutchinson M, Kjærgaard M, Sneve M and Grimnes G: Supplementation with High Doses of Vitamin D to Subjects without Vitamin D Deficiency May Have Negative Effects: Pooled Data from Four Intervention Trials in Tromsø. ISRN Endocrinol 2013: 348705, 2013.
89. Davidson MB, Duran P, Lee ML and Friedman TC: High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 36: 260-266, 2013.
90. 3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95: 1357-1364, 2012.
91. Autier P, Gandini S and Mullie P: A systematic review: influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J Clin Endocrinol Metab 97: 2606-2613, 2012.
92. Zittermann A, Ernst JB, Gummert JF and Börgermann J: Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr 53: 367-374, 2014.
93. 3 supplementation: A meta-regression analysis. Nutrition 30: 975-985, 2014.
94. Reid IR: Cardiovascular effects of calcium supplements. Nutrients 5: 2522-2529, 2013.
95. Bogh MK: Vitamin D production after UVB: aspects of UV-related and personal factors. Scand J Clin Lab Invest Suppl 243: 24-31, 2012.
96. Bogh MK, Schmedes AV, Philipsen PA, Thieden E and Wulf HC: A small suberythemal ultraviolet B dose every second week is sufficient to maintain summer vitamin D levels: a randomized controlled trial. Br J Dermatol 166: 430-433, 2012.
97. Wacker M and Holick MF: Sunlight and vitamin D: a global perspective for health. Dermatoendocrinol 5: 51-108, 2012.
98. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD, Dastani Z, Li R, Houston DK, Wood AR, Michaëlsson K, Vandenput L, Zgaga L, Yerges-Armstrong LM, McCarthy MI, Dupuis J, Kaakinen M, Kleber ME, Jameson K, Arden N, Raitakari O, Viikari J, Lohman KK, Ferrucci L, Melhus H, Ingelsson E, Byberg L, Lind L, Lorentzon M, Salomaa V, Campbell H, Dunlop M, Mitchell BD, Herzig KH, Pouta A, Hartikainen AL; Genetic Investigation of Anthropometric Traits-GIANT Consortium, Streeten EA, Theodoratou E, Jula A, Wareham NJ, Ohlsson C, Frayling TM, Kritchevsky SB, Spector TD, Richards JB, Lehtimäki T, Ouwehand WH, Kraft P, Cooper C, März W, Power C, Loos RJ, Wang TJ, Järvelin MR, Whittaker JC, Hingorani AD and Hyppönen E: Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10: e1001383, 2013.
99. Earthman CP, Beckman LM, Masodkar K and Sibley SD: The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes (Lond) 36: 387-96, 2012.
100. Wicherts IS, Boeke AJ, van der Meer IM, van Schoor NM, Knol DL and Lips P: Sunlight exposure or vitamin D supplementation for vitamin D-deficient non-western immigrants: a randomized clinical trial. Osteoporos Int 2011; 22: 873-82.
101. Kupferschmidt K: Uncertain verdict as vitamin D goes on trial. Science 337: 1476-1478, 2012.
102. Pilz S, Rutters F and Dekker JM: Disease prevention: vitamin D trials. Science 338: 883, 2012.
103. Péter S, Moser U, Pilz S, Eggersdorfer M and Weber P: The challenge of setting appropriate intake recommendations for vitamin E: considerations on status and functionality to define nutrient requirements. Int J Vitam Nutr Res 83: 129-136, 2013.
104. Robinson I, de Serna DG, Gutierrez A and Schade DS: Vitamin E in humans: an explanation of clinical trial failure. Endocr Pract 12: 576-582, 2006.